Cibus, Inc. (CBUS)Healthcare | Biotechnology | San Diego, United States | NasdaqCM
1.32 USD
+0.03
(2.326%)
⇧
(Oct. 16, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 5:35 a.m. EDT
The long-term investment case is severely compromised by a catastrophic multi-year decline; the stock has lost 99.9% of its value over the last eight years, with the most recent two years showing consecutive negative returns. This trajectory, combined with negative earnings, massive debt-to-equity leverage, and negative free cash flow, indicates a business in distress rather than a value opportunity. The short-term outlook remains fragile despite the aggressive call buying, as the underlying fundamentals—specifically the inability to generate profit or cash—are deteriorating. The recent price action shows some volatility, but the structural damage to the company's balance sheet and revenue generation makes any rally highly suspect. With no dividend to provide income and a history of massive capital destruction, this is a high-risk speculative vehicle masquerading as a biotech play. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.145940 |
| AutoETS | 0.145941 |
| MSTL | 0.154812 |
| AutoTheta | 0.284366 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 33% |
| H-stat | 7.11 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.156 |
| Excess Kurtosis | -0.82 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 1933.935 |
| Revenue per Share | 0.07 |
| Market Cap | 100,886,232 |
| Forward P/E | -2.08 |
| Beta | 1.57 |
| Previous Name | Calyxt, Inc. |
| Website | https://www.cibus.com |
As of Oct. 10, 2026, 5:35 a.m. EDT: Speculators are overwhelmingly bullish, positioning exclusively in calls with zero put volume recorded across all expirations. Open interest is concentrated in out-of-the-money strikes ($2.50 and $5.00), suggesting a speculative bet on a significant price surge rather than hedging against downside risk. Implied volatility remains extremely low, indicating a lack of pricing for potential moves despite the heavy call positioning.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.16774195 |
| Address1 | 6,455 Nancy Ridge Drive |
| All Time High | 1,594.5 |
| All Time Low | 1.09 |
| Ask | 1.67 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 125,770 |
| Average Daily Volume3 Month | 133,346 |
| Average Volume | 133,346 |
| Average Volume10Days | 125,770 |
| Beta | 1.569 |
| Bid | 0.9576 |
| Bid Size | 2 |
| Book Value | 0.194 |
| City | San Diego |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.32 |
| Current Ratio | 1.624 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 1.35 |
| Day Low | 1.295 |
| Debt To Equity | 1,933.935 |
| Display Name | Cibus |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,786,653,000 |
| Earnings Call Timestamp Start | 1,786,653,000 |
| Earnings Timestamp | 1,794,513,600 |
| Earnings Timestamp End | 1,794,513,600 |
| Earnings Timestamp Start | 1,794,513,600 |
| Ebitda | -48,869,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -7.504 |
| Enterprise To Revenue | 84.361 |
| Enterprise Value | 366,718,240 |
| Eps Current Year | -0.765 |
| Eps Forward | -0.635 |
| Eps Trailing Twelve Months | -1.62 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.6243 |
| Fifty Day Average Change | -0.30429995 |
| Fifty Day Average Change Percent | -0.18734221 |
| Fifty Two Week Change Percent | -16.774195 |
| Fifty Two Week High | 4.191 |
| Fifty Two Week High Change | -2.8709998 |
| Fifty Two Week High Change Percent | -0.68503934 |
| Fifty Two Week Low | 1.09 |
| Fifty Two Week Low Change | 0.23000002 |
| Fifty Two Week Low Change Percent | 0.21100919 |
| Fifty Two Week Range | 1.09 - 4.191 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,500,557,400,000 |
| Float Shares | 57,241,473 |
| Forward Eps | -0.635 |
| Forward P E | -2.0787404 |
| Free Cashflow | -52,461,752 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 118 |
| Fullday Change | 0.03000009 |
| Fullday Change Percent | 2.3437574 |
| Fullday Price | 1.32 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 1.0 |
| Gross Profits | 4,347,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.261 |
| Held Percent Institutions | 0.29181 |
| Implied Shares Outstanding | 76,428,964 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,685,577,600 |
| Last Split Factor | 1:5 |
| Long Business Summary | Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California. |
| Long Name | Cibus, Inc. |
| Market | us_market |
| Market Cap | 100,886,232 |
| Market State | POST |
| Max Age | 86,400 |
| Message Board Id | finmb_128307114 |
| Most Recent Quarter | 1,782,777,600 |
| Name Change Date | 2,026-10-16 |
| Net Income To Common | -98,194,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 117,700,604 |
| Number Of Analyst Opinions | 3 |
| Open | 1.3 |
| Operating Cashflow | -46,054,000 |
| Operating Margins | -13.00302 |
| Phone | 858 450 0008 |
| Prev Name | Calyxt, Inc. |
| Previous Close | 1.29 |
| Price Eps Current Year | -1.7254903 |
| Price Hint | 4 |
| Price To Book | 6.804124 |
| Price To Sales Trailing12 Months | 23.208242 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.493 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.03000009 |
| Regular Market Change Percent | 2.3255885 |
| Regular Market Day High | 1.35 |
| Regular Market Day Low | 1.295 |
| Regular Market Day Range | 1.295 - 1.35 |
| Regular Market Open | 1.3 |
| Regular Market Previous Close | 1.29 |
| Regular Market Price | 1.32 |
| Regular Market Time | 1,792,180,801 |
| Regular Market Volume | 45,712 |
| Return On Assets | -0.10222 |
| Return On Equity | -2.23164 |
| Revenue Growth | 0.065 |
| Revenue Per Share | 0.07 |
| Sand P52 Week Change | 0.16207206 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 76,428,964 |
| Shares Percent Shares Out | 0.0434 |
| Shares Short | 3,316,848 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 3,469,651 |
| Short Name | Cibus, Inc. |
| Short Percent Of Float | 0.0583 |
| Short Ratio | 27.93 |
| Source Interval | 15 |
| State | CA |
| Symbol | CBUS |
| Target High Price | 25.0 |
| Target Low Price | 2.0 |
| Target Mean Price | 14.33333 |
| Target Median Price | 16.0 |
| Total Cash | 20,429,000 |
| Total Cash Per Share | 0.267 |
| Total Debt | 286,260,992 |
| Total Revenue | 4,347,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.62 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.8808 |
| Two Hundred Day Average Change | -0.56079996 |
| Two Hundred Day Average Change Percent | -0.29817095 |
| Type Disp | Equity |
| Volume | 45,712 |
| Website | https://www.cibus.com |
| Zip | 92,121 |